Teva

News

Lilly pushes into migraine market as Emgality approved in US

The FDA has approved Eli Lilly’s Emgality (galcanezumab) for migraine prevention in adults, the third in a group of new class of drugs for the condition.

News

FDA approves Teva's migraine drug, decision due on Lilly's r...

The FDA has finally approved Teva’s potential blockbuster migraine drug Ajovy after months of delays due to concerns about the manufacturing plant operated by the company’s partner, Celltri

News

Teva holding off launch of opioid addiction drug

Drugmaker awaiting outcome of separate court case

News

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer and Eli Lilly are competitors in NGF research

News

Concerns over Teva migraine drug because of manufacturing is...

There are concerns that launch of Teva’s migraine drug may be delayed because of issues uncovered by the FDA at a manufacturing plant run by South Korea’s Celltrion.

White Papers

medical technology or medical network. doctor using digital tablet with screen interface."n

Remote HCP engagement – still a struggle for life science co...

Life science companies are failing to achieve their full digital potential, particularly when it comes to the use of remote channels for effective physician engagement.

Lilly pushes into migraine market as Emgality approved in US

FDA approves Teva's migraine drug, decision due on Lilly's r...

Teva holding off launch of opioid addiction drug

Regeneron/Teva pain drug fasinumab on target in phase 3

Concerns over Teva migraine drug because of manufacturing is...

Remote HCP engagement – still a struggle for life science co...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Teva

Editor's Picks